Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qlarista vs Yasmin for Primary Dysmenorrhea
NCT03124524Phase 4Completed
- Sponsor
- Adana Numune Training and Research Hospital
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of estradiol valerate + dienogest in primary dysmenorrhea (PD) (3 arms), sponsored by Adana Numune Training and Research Hospital. Primary endpoint: Uterine artery Doppler indices at 3 months. Started Jan 2015; status: completed.
02
Drugs
estradiol valerate + dienogest
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT03124524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124524.